Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn
- 15 January 2009
- journal article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 18 (3), 246-252
- https://doi.org/10.1002/pds.1710
Abstract
Purpose To determine the prevalence of persistent pulmonary hypertension of the newborn (PPHN) among infants whose mothers were exposed to antidepressants in the third trimester of pregnancy compared to the prevalence among infants whose mothers were not exposed to antidepressants in the third trimester. Methods A retrospective study was conducted using the automated databases of four health plans participating in the HMO Research Network Center for Education and Research on Therapeutics. Women who delivered an infant in a hospital from 1 January 1996 through 31 December 2000 were identified. The administrative databases were used to identify full‐term infants whose mothers received an antidepressant during the third trimester of pregnancy and unexposed infants whose mothers did not receive an antidepressant during the third trimester. Hospitalization data were used to identify diagnoses or procedure codes potentially indicative of PPHN. Results Among 1104 infants exposed to antidepressants in the third trimester and a matched sample of 1104 unexposed infants, five infants were classified by the expert reviewers as having PPHN. Among those infants whose mothers were exposed to selective serotonin reuptake inhibitors (SSRIs) in the third trimester, the prevalence of PPHN was 2.14 per 1000 (95% confidence interval (CI) 0.26, 7.74), while the prevalence among infants whose mothers were not exposed was 2.72 per 1000 (95%CI 0.56, 7.93). Conclusions We did not find an association between SSRI use in late pregnancy and PPHN. Limitations of the present study, including the small number of confirmed cases, suggest further research in this area may be warranted. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 14 references indexed in Scilit:
- Use of antidepressant medications during pregnancy: a multisite studyAmerican Journal of Obstetrics and Gynecology, 2008
- Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancyPharmacoepidemiology and Drug Safety, 2007
- Risk Factors for Persistent Pulmonary Hypertension of the NewbornPEDIATRICS, 2007
- Increasing use of antidepressants in pregnancyAmerican Journal of Obstetrics and Gynecology, 2007
- First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth DefectsThe New England Journal of Medicine, 2007
- Maternal use of selective serotonin re‐uptake inhibitors in early pregnancy and infant congenital malformationsBirth Defects Research Part A: Clinical and Molecular Teratology, 2007
- Selective serotonin reuptake inhibitors and adverse pregnancy outcomesAmerican Journal of Obstetrics and Gynecology, 2006
- Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the NewbornThe New England Journal of Medicine, 2006
- New approaches for persistent pulmonary hypertension of newbornClinics in Perinatology, 2004
- Persistent Pulmonary Hypertension of the NewbornAmerican Journal of Diseases of Children, 1984